Skip to main content
Informational

Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Arnuity® Ellipta® (fluticasone furoate) – First-time authorized brand alternative

July 22, 2025 - Prasco launched an authorized brand alternative of GSK’s Arnuity Ellipta (fluticasone furoate) inhaler.

Download PDF